Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Lin

Urology

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Urology|March 26, 2014
Editorial commentDaniel W Lin
Urology|September 19, 2008
Primary scrotal cancer: disease characteristics and increasing incidenceJonathan L Wright, Todd M Morgan, Daniel W Lin
Urology|December 5, 2006
Incidence of primary urethral carcinoma in the United StatesMia A Swartz, Michael P Porter, Daniel W Lin, et al.
Urology|July 25, 2016
Predictors of Nodal Upstaging in Clinical Node Negative Patients With Penile Carcinoma: A National Cancer Database AnalysisBrian R Winters, Matthew Mossanen, Sarah K Holt, et al.
Urology|August 15, 2006
Incidence of testicular germ cell cancers in U.S. children: SEER program experience 1973 to 2000Thomas J Walsh, Richard W Grady, Michael P Porter, et al.
Urology|June 18, 2016
Extreme Gleason Upgrading From Biopsy to Radical Prostatectomy: A Population-based AnalysisBrian R Winters, Jonathan L Wright, Sarah K Holt, et al.
Urology|September 18, 2009
Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepositoryLisa F Newcomb, James D Brooks, Peter R Carroll, et al.
Urology|July 23, 2015
Trends in Metastatic Kidney Cancer Survival From the Cytokine to the Targeted Therapy EraLiam C Macleod, Scott S Tykodi, Sarah K Holt, et al.
Urology|January 31, 2026
Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancerMehmet A Bilen, Neal Shore, Sabree Burbage, et al.
Urology|April 15, 2008
Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancerBruce Montgomery, Philip Lavori, Mark Garzotto, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Urology|March 26, 2014
Editorial commentDaniel W Lin
Urology|September 19, 2008
Primary scrotal cancer: disease characteristics and increasing incidenceJonathan L Wright, Todd M Morgan, Daniel W Lin
Urology|December 5, 2006
Incidence of primary urethral carcinoma in the United StatesMia A Swartz, Michael P Porter, Daniel W Lin, et al.
Urology|July 25, 2016
Predictors of Nodal Upstaging in Clinical Node Negative Patients With Penile Carcinoma: A National Cancer Database AnalysisBrian R Winters, Matthew Mossanen, Sarah K Holt, et al.
Urology|August 15, 2006
Incidence of testicular germ cell cancers in U.S. children: SEER program experience 1973 to 2000Thomas J Walsh, Richard W Grady, Michael P Porter, et al.
Urology|June 18, 2016
Extreme Gleason Upgrading From Biopsy to Radical Prostatectomy: A Population-based AnalysisBrian R Winters, Jonathan L Wright, Sarah K Holt, et al.
Urology|September 18, 2009
Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepositoryLisa F Newcomb, James D Brooks, Peter R Carroll, et al.
Urology|July 23, 2015
Trends in Metastatic Kidney Cancer Survival From the Cytokine to the Targeted Therapy EraLiam C Macleod, Scott S Tykodi, Sarah K Holt, et al.
Urology|January 31, 2026
Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancerMehmet A Bilen, Neal Shore, Sabree Burbage, et al.
Urology|April 15, 2008
Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancerBruce Montgomery, Philip Lavori, Mark Garzotto, et al.
Pageof 2